Operating Lease, Right-of-Use Asset of IDEAYA Biosciences, Inc. from 01 Jan 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
IDEAYA Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 31 Dec 2025.
  • IDEAYA Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $23,068,000, a 23% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

IDEAYA Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $23,068,000 +$4,293,000 +23% 31 Dec 2025 10-K 17 Feb 2026 2025 FY
Q3 2025 $23,544,000 +$5,159,000 +28% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $23,913,000 +$22,608,000 +1732% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $24,428,000 +$22,648,000 +1272% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $18,775,000 +$16,529,000 +736% 31 Dec 2024 10-K 17 Feb 2026 2025 FY
Q3 2024 $18,385,000 +$17,038,000 +1265% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 $1,305,000 -$428,000 -25% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $1,780,000 -$332,000 -16% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $2,246,000 -$238,000 -9.6% 31 Dec 2023 10-K 18 Feb 2025 2024 FY
Q3 2023 $1,347,000 -$1,501,000 -53% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $1,733,000 -$1,471,000 -46% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $2,112,000 -$1,442,000 -41% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $2,484,000 -$1,414,000 -36% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q3 2022 $2,848,000 -$1,386,000 -33% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $3,204,000 -$1,359,000 -30% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $3,554,000 -$1,333,000 -27% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $3,898,000 -$1,307,000 -25% 31 Dec 2021 10-K 07 Mar 2023 2022 FY
Q3 2021 $4,234,000 -$1,281,000 -23% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $4,563,000 -$31,000 -0.68% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 $4,887,000 +$59,000 +1.2% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $5,205,000 +$148,000 +2.9% 31 Dec 2020 10-K 18 Mar 2022 2021 FY
Q3 2020 $5,515,000 +$236,000 +4.5% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $4,594,000 -$951,000 -17% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 $4,828,000 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 $5,057,000 -$1,043,000 -17% 31 Dec 2019 10-K 23 Mar 2021 2020 FY
Q3 2019 $5,279,000 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 $5,545,000 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q4 2018 $6,100,000 01 Jan 2019 10-K 24 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.